Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Chemical Exposure Linked To Cardiovascular Disease

Date: Sep-06-2012
Exposure to perfluorooctanoic acid (PFOA), which is found in some household products, has been linked to cardiovascular disease (CVD) and peripheral arterial disease. Researchers in Chicago found an association between higher levels of PFOA and incidence of cardiovascular disease. The chemical, used in products such as polishes, paper and food packaging, is detectable in the blood of more than 98 percent of the US population. One limitation to the study is that researchers relied on self-reported data about people's diagnosis with CVD...

IBS-C And Chronic Idiopathic Constipation Treatment LINZESS (Linaclotide) Receives FDA Approval

Date: Sep-06-2012
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today that LINZESS™ (linaclotide) was approved by the U.S. Food and Drug Administration (FDA) as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC)...

Asthma Treatment With Omalizumab (Xolair®), New Data Shows Benefits

Date: Sep-06-2012
New data analyses presented at the European Respiratory Society (ERS) Annual Congress in Vienna show that long-term treatment with omalizumab (Xolair®) significantly improves a range of outcomes for people with severe persistent allergic asthma, a chronic condition affecting an estimated 14,315 people in the UK4. Asthma can be a devastating condition, causing an average of three deaths in the UK every day, 90% of which are preventable with optimal management5...

Lucentis® (Ranibizumab) For Treating Visual Impairment Due To Diabetic Macular Oedema, Study Shows New Evidence

Date: Sep-06-2012
RESTORE extension study demonstrates fully maintained initial vision gains with an average of 13.9 ranibizumab 0.5mg injections over three years for patients with visual impairment due to DMO (VI-DMO)[i] New data for Lucentis® (ranibizumab) has demonstrated improvement in visual acuity achieved with individualised treatment after one year is maintained for up to three years on average in patients with VI-DMO, with fewer injections in years two and three compared to the first year and no additional or new safety risks identified1...

Why Do Women Gain Belly Fat Easier Than Men?

Date: Sep-06-2012
A new study conducted on mice and published in the journal Diabetes has revealed that high fat diets set off chemical reactions in female mice. This discovery could explain why it is easier for women to store fat in their abdomen area than men. The trial also touched base on what causes women to gain more fat in their bellies after menopause. The experts explained a process in female mice which begins with an enzyme being activated and ending when visceral fat forms...

Problems Sleeping May Indicate Alzheimer's Risk

Date: Sep-06-2012
According to a team of researchers at Washington University School of Medicine, one of the first signs of Alzheimer's disease is sleep disruptions. The finding came from a mouse experiment which showed that the regular sleep-wake cycle is seriously disrupted when the earliest indicators of Alzheimer's plaques become visible in the brain. David M. Holtzman, M.D., head researcher, the Andrew B. and Gretchen P...

A Male Birth Control Pill May Soon Be A Possibility

Date: Sep-06-2012
A recent study, published in the journal Cell and conducted by a team of researchers, including a Texas A&M scientist, claims that it may be sooner than later that men can begin taking their own birth control pills, instead of just women. Qinglei Li, an assistant professor in Texas A&M's College of Veterinary Medicine & Biomedical Sciences worked under the lead of Martin Matzuk from Baylor College of Medicine and James Bradner at Dana-Farber Cancer Institute, the expert behind the discovery...

Hospitals Are Penalized For Some Common Hospital Acquired Infections

Date: Sep-06-2012
A study by the University of Michigan shows a Medicare policy that withholds excess payments for catheter-associated urinary tract infections during hospital stays, seldom changes payments. In 2008, this Medicare policy, aimed at cutting costs and improving care, stopped paying hospitals extra to treat preventable hospital-obtained UTIs. Infections included those obtained after a catheter had been put in place. U-M authors say that this policy is using inaccurate data for identifying these complications...

Medicare Kidney Spending At Crucial Moment

Date: Sep-06-2012
Amid a presidential campaign and facing the "fiscal cliff," Americans hear a lot about federal spending, particularly for Medicare. But few probably know of either the history or the present watershed moment in the program's 40-year struggle to contain costs and finance quality treatment for Americans with end-stage renal disease...

Witch Hunts Targeted By Grassroots Women's Groups

Date: Sep-06-2012
Witch hunts are common and sometimes deadly in the tea plantations of Jalpaiguri, India. But a surprising source - small groups of women who meet through a government loan program - has achieved some success in preventing the longstanding practice, a Michigan State University sociologist found. Soma Chaudhuri spent seven months studying witch hunts in her native India and discovered that the economic self-help groups have made it part of their agenda to defend their fellow plantation workers against the hunts...